Collagen Peptides

The old objection to oral collagen - that it is just protein and gets digested into amino acids - turned out to be only partly true. A measurable fraction survives as small proline-hydroxyproline containing peptides, and Pro-Hyp in particular has been detected in human plasma after ingestion and shown in culture to act as a chemoattractant and growth signal for fibroblasts. Hydrolysates are also enriched in glycine, proline and hydroxyproline, the exact substrate limitation for building new collagen. Molecular weights matter: hydrolysates in the two to five kilodalton range are the ones used in the positive trials, whereas gelatin and whole collagen behave more like ordinary protein. The best-supported outcomes are skin elasticity and hydration, joint pain in athletes and osteoarthritis, and tendon and ligament stiffness when combined with loading.

Targets: Dermal and tendon fibroblasts, Collagen type I and III synthesis, Proteoglycan and elastin synthesis, Chondrocyte matrix production

• · 2.5 to 5 grams daily is the dose used in the Verisol skin elasticity trials. Note the microgram figures here translate to grams - this is a food-scale dose, not a peptide-scale one.
• · 10 grams daily is the standard dose in osteoarthritis and athletic knee pain trials, typically run for three to six months before judging.
• · 15 grams of gelatin or collagen hydrolysate with about 50 mg of vitamin C, taken an hour before six to ten minutes of targeted loading. The timing is the whole point - blood amino acid levels need to peak while the tissue is being loaded.

Work out your exact syringe units →

• commonUnpleasant taste or aftertaste— Marine collagen is the usual culprit.
• uncommonBloating or fullness— More common at 15-20 gram doses.
• rareAllergic reaction— Relevant for fish-derived collagen in anyone with a fish or shellfish allergy.

• Fish or shellfish allergy, for marine-sourced collagen specifically.
• Nothing else meaningful - this is a hydrolysed food protein.

• synergyVitamin C — Vitamin C is a required cofactor for prolyl hydroxylase in collagen synthesis; the tendon protocols pair them deliberately.
• synergybpc-157 — Commonly combined for tendon work - substrate plus signalling, at least in theory.
• cautionWhey or other complete proteins — Collagen is not a complete protein and should not displace your total protein intake; it lacks tryptophan entirely.

• · Judge by function - tendon load tolerance, joint pain scores, skin measurements - across a three to six month window, not by week.

Sold worldwide as a food supplement with no restrictions.

• Proksch et al., oral supplementation of specific collagen peptides improves skin elasticity, Skin Pharmacology and Physiology (trial)
• Shaw et al. 2017, vitamin C-enriched gelatin supplementation before intermittent activity augments collagen synthesis, American Journal of Clinical Nutrition (trial)
• Clark et al., 24-week study on the use of collagen hydrolysate for activity-related joint pain in athletes (trial)

Two mechanisms operate at once and they are frequently conflated. The first is substrate. Collagen is roughly one-third glycine with unusually high proline and hydroxyproline content, and those are exactly the amino acids you need in bulk to build more collagen. A normal mixed diet is not obviously limiting for them, but under high synthetic demand - a healing tendon, a remodelling dermis - supplying them directly is at least plausible. This is the boring half of the mechanism and it requires no special pleading. The second is signalling, and it is the more interesting one. Pro-Hyp survives digestion, reaches plasma intact and has been shown in culture to act as a chemoattractant and growth signal for fibroblasts, driving proliferation and matrix synthesis. That reframes collagen hydrolysate from 'protein with a good amino acid profile' to 'protein that also delivers a small dose of a fibroblast signal'. It is a real finding, and it is also a small effect - which matches the modest effect sizes in the clinical literature. The timing consequence is the most practically useful thing here. Plasma Pro-Hyp peaks at one to two hours and is gone by four to six. Tendon and ligament have poor blood supply, so their exposure to any circulating substrate is brief and depends on blood flow - which increases with loading. Shaw's crossover study in eight men found that 15 g of vitamin C-enriched gelatin taken an hour before a short bout of intermittent activity doubled the amino-terminal propeptide of collagen I in blood, a direct marker of collagen synthesis. Five grams did not do it; 15 g did. So the protocol is not folklore: peak the substrate, then load the tissue while it is peaked. The vitamin C pairing is also mechanistic rather than decorative. Prolyl hydroxylase requires ascorbate as a cofactor to make hydroxyproline. Supplying collagen substrate without the cofactor to process it is a half-finished intervention. What this mechanism does not support: collagen peptides do not selectively go to the tissue you want. There is no targeting. The dermis and the patellar tendon get the same systemic exposure.

The most common failure is taking it at the wrong time and expecting the tendon result. The entire mechanistic case for tendon rests on peak plasma Pro-Hyp coinciding with tissue loading, because the tissue is poorly vascularised and only gets meaningful exposure when blood flow rises. Collagen in your evening shake does nothing for a tendon you trained that morning. The second is under-dosing for the goal. Five grams did not raise collagen synthesis markers in the mechanistic study; 15 g did. And the doses differ by target - 2.5-5 g for skin, 10 g for joints, 15 g pre-loading for tendon. Taking 5 g and expecting the tendon effect is running the skin protocol. The third is quitting early. Skin elasticity changes take 8-12 weeks. Joint pain trials ran 24 weeks. Tendon adaptation is a 12-week-plus question. This is the slowest-acting intervention in this class and the one where people most often stop at six weeks. The fourth is protein displacement. Collagen has no tryptophan and a poor amino acid profile. If your 15 g of collagen is replacing 15 g of whey rather than adding to your intake, you have made your diet worse to improve a tendon. The fifth is the industry funding problem, which affects how you should read the literature rather than what you should do. Almost every positive trial in this space is funded by a hydrolysate manufacturer, and effect sizes are modest even in those trials. That does not make the findings wrong - it makes them worth discounting slightly. And for anyone with a calcium oxalate stone history: hydroxyproline is metabolised partly to oxalate, and 15 g daily is a real hydroxyproline load. Keep fluid intake high.

• Dermal and tendon fibroblasts — Pro-Hyp acts as a chemoattractant and proliferative signal in culture; no receptor has been definitively identified

  Increased fibroblast proliferation and matrix synthesis. The signalling half of the mechanism.

• Collagen type I and III synthesis — Downstream cellular endpoint

  Measurable as increased amino-terminal propeptide of collagen I in blood after loading, which is the most direct human evidence that anything is happening.

• Proteoglycan and elastin synthesis — Downstream cellular endpoint

  Contributes to the skin elasticity and hydration findings in the dermatological trials.

• Prolyl hydroxylase (indirectly, via vitamin C) — Not a target of the peptide - an enzyme requiring ascorbate as cofactor

  The rate-limiting hydroxylation step in collagen synthesis. This is why vitamin C is paired with the dose rather than taken separately.

• Chondrocyte matrix production — Downstream cellular endpoint

  The proposed basis for the joint pain findings in osteoarthritis and athlete trials.

• Oral supplementation of specific collagen peptides has beneficial effects on human skin physiology (randomised, double-blind, placebo-controlled) Randomised controlled trial · n=69 · 12 weeks · 2014

  69 women aged 35-55 given 2.5 g or 5.0 g collagen hydrolysate daily for eight weeks with a four-week follow-up. Skin elasticity improved significantly versus placebo in both dose groups. The trial behind the 2.5-5 g skin protocol.

• 24-week study on the use of collagen hydrolysate as a dietary supplement in athletes with activity-related joint pain Randomised controlled trial · n=97 · 24 weeks · 2008

  97 of 147 recruited athletes completed 24 weeks of 10 g collagen hydrolysate daily in 25 mL of liquid. Six parameters reached statistical significance, including joint pain at rest and during activity, with the strongest effect in the subgroup with knee arthralgia. The trial behind the 10 g joint protocol.

• Vitamin C-enriched gelatin supplementation before intermittent activity augments collagen synthesis Randomised crossover mechanistic study · n=8 · 1 weeks · 2017

  8 healthy men, 5 g or 15 g of vitamin C-enriched gelatin taken one hour before short bouts of intermittent activity. The 15 g dose doubled blood amino-terminal propeptide of collagen I, indicating increased collagen synthesis; 5 g did not. Small but mechanistically decisive, and the origin of the 15 g pre-loading tendon protocol.

Hours 1-2: plasma Pro-Hyp peaks. This is the only fast thing about this compound and it is the window the tendon protocol exploits. Hours 4-6: back to baseline. Nothing is circulating; whatever synthetic signal you generated has been given. Weeks 8-12: skin elasticity and hydration changes become measurable, which is when the dermatological trials assessed them. Weeks 12+: tendon and ligament stiffness changes with a loading protocol. This is the slowest endpoint and the one most dependent on the exercise half of the protocol. Months 3-6: joint pain improvement in osteoarthritis and athlete trials. The 24-week trial found significant effects; shorter courses generally have not.

The vitamin C pairing is not optional and it is not a general antioxidant gesture - ascorbate is the cofactor for the hydroxylation step in collagen synthesis. Fifty milligrams with the dose is what the tendon protocol uses. Taking your vitamin C at breakfast and your collagen at night misses the point entirely. With BPC-157 for tendon work the combination is substrate plus signalling, which is the most sensible framing of any peptide stack in this class - though it is worth being honest that the substrate half has the human evidence and the signalling half does not. With loading, and this is the real stack: collagen peptides without mechanical loading of the target tissue are a much weaker intervention. The Shaw protocol is a peptide protocol and an exercise protocol fused together, and the exercise is not the optional part. Six to ten minutes of loaded, low-intensity work on the target tissue an hour after the dose. Against whey and other complete proteins, treat this as an addition rather than a substitution. Collagen lacks tryptophan entirely and is a poor protein by any quality metric. Displacing complete protein with it is a downgrade. With GHK-Cu topically there is a coherent skin story - substrate from one, transcriptional signal and lysyl oxidase cofactor from the other - though nobody has tested the combination.

Against every injectable in this class: collagen peptides have the best human evidence for tendon and joint outcomes by a wide margin, and they are a food. Multiple randomised placebo-controlled trials and meta-analyses versus rodent studies is not a close comparison. The effect sizes are modest, the industry funding is pervasive, and it is still the best-evidenced thing on this shelf. Against BPC-157 for tendinopathy: collagen peptides plus loading has human mechanistic evidence; BPC-157 has rodent explant data. Doing both is reasonable. Doing only BPC-157 while skipping the loaded rehab is the expensive version of the same decision. Against whey protein for building tissue generally: whey wins on protein quality and muscle protein synthesis. Collagen's argument is specific to collagenous tissue and the Pro-Hyp signalling effect, not to protein adequacy. Against gelatin: gelatin is cheaper and was what the Shaw tendon study actually used. It needs warm liquid to dissolve and is less convenient. For the pre-loading tendon protocol, gelatin is the evidence-matched choice; for skin and joints, the 2-5 kDa hydrolysates are what the trials used. Against glucosamine and chondroitin for joint pain: comparable modest effect sizes, comparably contested literature. Collagen hydrolysate has the better mechanistic story because of the Pro-Hyp plasma data.

$15–$60/month. Bulk unflavoured hydrolysate at 10-15 g daily sits at the low end; branded and clinically-studied hydrolysates such as the ones used in the trials cost more. Gelatin, used in the Shaw protocol, is cheaper still. Order-of-magnitude estimate, not price-checked in the preparation of this entry.

• ?The absolute fraction of ingested collagen surviving as bioactive di- and tripeptides has not been pinned to a single figure and varies with hydrolysate molecular weight distribution.
• ?No volume of distribution, clearance or protein binding figures exist for Pro-Hyp; the 1-2 hour peak and 4-6 hour clearance are approximations from plasma appearance studies.
• ?Whether marine, bovine, porcine and chicken hydrolysates differ meaningfully in bioactive fragment content is not well established, despite marketing claims that they do.
• ?The Shaw tendon protocol rests on a crossover study in eight men using a surrogate blood marker, not on a clinical tendon outcome.
• ?Industry funding is pervasive across this literature and effect sizes are modest, which is a reason to discount rather than dismiss.
• ?Whether collagen peptides do anything for a tendon that is not being loaded has not been tested and there is mechanistic reason to doubt it.
• ?The oxalate load from high-dose hydroxyproline in stone-formers is a plausible concern that has not been properly studied.
• ?Cost figures are estimates and were not price-verified in this session.

• Oral supplementation of specific collagen peptides has beneficial effects on human skin physiology: a double-blind, placebo-controlled study Proksch E, Segger D, Degwert J, Schunck M, Zague V, Oesser S, Skin Pharmacology and Physiology, 2014 · PMID 23949208

  The skin elasticity trial that established the 2.5-5 g dose. Industry-linked, like most of this literature, but properly randomised and placebo-controlled.

• 24-Week study on the use of collagen hydrolysate as a dietary supplement in athletes with activity-related joint pain Clark KL et al., Current Medical Research and Opinion, 2008 · PMID 18416885

  The joint pain trial behind the 10 g protocol, and a useful illustration of how long these effects take - 24 weeks.

• Vitamin C-enriched gelatin supplementation before intermittent activity augments collagen synthesis Shaw G, Lee-Barthel A, Ross ML, Wang B, Baar K, American Journal of Clinical Nutrition, 2017 · PMID 27852613

  The most mechanistically important paper in this entry. Eight subjects, but it establishes the dose threshold, the timing rationale and the vitamin C requirement all at once.